CClinicalTrials.gg
CompletedNCT03680807Updated Feb 8, 2019

Power Production in Older Adults With Knee Osteoarthritis

An observational study in Osteo Arthritis Knee, sponsored by KU Leuven. Completed at 1 site in Belgium. Open to participants aged 50 Years to 80 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2019-02-08.

Sponsored by KU Leuven · Observational

Study type
Observational
Model
Case-control
Time perspective
Cross-sectional
Enrollment
48
Ages
50 Years to 80 Years
Sex
All
01

Study summary

Knee osteoarthritis is an important cause of functional disabilities at old age. Previous research has demonstrated that individuals with knee osteoarthritis have reduced knee-extensor strength in comparison to healthy individuals. However, rapid power production declines more than strength as a consequence of ageing and is more predictive of functional capacity. However, limited research has investigated whether individuals with knee osteoarthritis have reduced ability to develop strength and power rapidly on top of reduced maximal strength capacities, which is the primary aim of the current study.

02

Conditions studied

  • Osteo Arthritis Knee

Keywords

  • Knee osteoarthritis
  • power production
  • functional capacity
03

In context

Osteoarthritis

4,398 studies on the registry are indexed under Osteoarthritis; 582 are open to participants now.

This study's enrollment of 48 is below the median of 100 across 791 observational studies indexed under Osteoarthritis.

Browse Osteoarthritis studies →

Lead sponsor

KU Leuven is the lead sponsor of 358 studies on the registry; 62 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
50 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Adults between 50 and 80 years with or without knee osteoarthritis. Subjects are sedentary or recreationally active.

Inclusion criteria

Group with knee osteoarthritis:

  • Diagnosed with knee osteoarthritis based on RX.

Exclusion criteria

Exclusion Criteria:

Healthy group:

  • Systematic engagement in (resistance) exercise in the 12-months prior to participation
  • Cardiovascular disease
  • Neurological disorders
  • Cognitive malfunctioning
  • Severe knee or hip problems

Group with knee osteoarthritis:

  • Systematic engagement in (resistance) exercise in the 12-months prior to participation
  • Cardiovascular disease
  • Neurological disorders
  • Cognitive malfunctioning
  • Severe hip problems
05

Study design

Observational model
Case-control
Time perspective
Cross-sectional
Enrollment
48 participants (actual)
Patient registry
No

Groups and cohorts

  • Older adults with knee osteoarthritis (>50 years)

    Diagnostic Test: Muscle function test

  • Healthy older adults (> 50 years)

    Diagnostic Test: Muscle function test

Interventions

  • Diagnostic testMuscle function test

    Power and strength tests of the knee-extensor muscles, handgrip strength, functional capacity tests

06

What researchers measure

Primary outcomes

  1. Rate of power development

    Subjects perform a test protocol on a Biodex dynamometer, consisting of isotonic contractions of the leg-extensor muscles. Subjects are instructed to kick as fast as possible against different (relative) loads. The rate of power development (watt/s) is defined as the linear slope of the power-time curve and is measured from the onset of movement till peak power.

    Time frame: up to 3 months

Secondary outcomes

  1. Maximal isometric strength

    Maximal strength (Nm) is measured by means of unilateral isometric knee-extensor tests on a Biodex dynamometer.

    Time frame: up to 3 months

  2. Maximal isokinetic strength

    Maximal strength (Nm) is measured by means of unilateral isokinetic knee-extensor tests on a Biodex dynamometer.

    Time frame: up to 3 months

  3. Stair Climbing performance

    Stair ascent duration (in s), the time needed to ascent a flight of stairs.

    Time frame: up to 3 months

  4. Gait speed

    The average speed to walk 10m as fast as possible (in m/s).

    Time frame: up to 3 months

  5. 5 repetition sit-to-stand test

    The time needed to perform 5 sit-to-stand transitions (in s).

    Time frame: up to 3 months

  6. Timed-up-and-go

    The time needed to stand up from a chair, walk 3m, turn, walk back and sit down.

    Time frame: up to 3 months

  7. Handgrip strength

    Handgrip strength (kg) evaluated with Jamar dynamometer.

    Time frame: up to 3 months

07

Study locations

1 site
  • Department of Movement Sciences
    Leuven, 3001, Belgium
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 8, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03680807
Lead sponsor
KU Leuven
Responsible party
Evelien Van Roie (Dr., KU Leuven) — Principal investigator
First posted
Sep 21, 2018
Start date
Sep 1, 2018
Primary completion
Dec 20, 2018
Completion
Dec 20, 2018
Last update
Feb 8, 2019

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion